RMD Financial Facts

Other, net (note 12): 1.27M
Cost of sales: 196.27M
See Full Income Statement

Accrued expenses (note 9): 153.97M
Total non-current liabilities: 929.14M
See Full Balance Sheet

ResMed Inc. (RMD) Earnings

  |   Expand Research on RMD
Next EPS Date 10/22/26 EPS Growth Rate +5.5%
Average EPS % Beat Rate +2.0% Revenue Growth Rate +6.9%
Average % Move 1-Wk after EPS -0.1% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
10/22/26 Q127 N/A$2.69 N/A N/A$1.39B N/A N/A N/A
8/6/26 Q426 $2.95$2.89 +$0.06$1.46B$1.47B N/A Details
4/30/26 Q326 $2.86$2.81 +$0.05$1.4B$1.42B N/A Details
1/29/26 Q226 $2.81$2.73 +$0.08$1.4B$1.4B N/A Details
10/30/25 Q126 $2.55$2.52 +$0.03$1.3B$1.33B N/A Details
7/31/25 Q425 $2.55$2.48 +$0.07$1.3B$1.33B N/A Details
4/23/25 Q325 $2.37$2.39 -$0.02$1.3B$1.29B N/A Details
1/30/25 Q225 $2.43$2.32 +$0.11$1.28B$1.27B N/A Details